Salivary gland homogenates of Lutzomyia longipalpis and its vasodilatory peptide maxadilan cause plasma leakage via PAC1 receptor activation

Journal of Vascular Research

Volumn 46, Issue 5, 2009, Pages 435-446

  Svensjö, Erik ^a   Saraiva, Elvira M ^a   Bozza, Marcelo T ^a   Oliveira, Sandra M P ^b   Lerner, Ethan A ^c   Scharfstein, Julio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Transplantation Biology Research Center   (United States)

Author keywords

Arteriolar dilation; Lutzomyia longipalpis; Maxadilan; PAC1 receptor; Pituitary adenylate cyclase activating peptide; Plasma leakage; Postcapillary venules; Salivary glands

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 2; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; ICATIBANT; MAXADILAN; MEPYRAMINE; N(G) NITROARGININE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CHEEK POUCH; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FLUORESCENCE; LUTZOMYIA LONGIPALPIS; MALE; MICROCIRCULATION; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PSYCHODIDAE; SALIVARY GLAND; TISSUE HOMOGENATE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARTERIOLES; BRADYKININ; CRICETINAE; ENZYME INHIBITORS; FEMALE; HISTAMINE H1 ANTAGONISTS; INSECT PROTEINS; MALE; MICROSCOPY, FLUORESCENCE; NITROARGININE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PLASMA; PSYCHODIDAE; PYRILAMINE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; SALIVARY GLANDS; VASODILATION; VASODILATOR AGENTS; VENULES;

EID: 58749100506     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000197866     Document Type: Article

References (52)

1. Ribeiro JM: Role of saliva in blood-feeding by arthropods. Annu Rev Entomol 1987; 32: 463-478.
2. Gillespie RD, Mbow ML, Titus RG: The immunomodulatory factors of bloodfeeding arthropod saliva. Parasite Immunol 2000; 22: 319-331.
3. WHO: Leishmaniasis: background information. www.who.int/leishmaniasis/en. 2008.
4. Soares RP, Turco SJ: Lutzomyia longipalpis (Diptera: Psychodidae: Phlebotominae): a review. An Acad Bras Cienc 2003; 75: 301-330.
5. Andrade BB, de Oliveira CI, Brodskyn CI, Barra A, Barral-Netto M: Role of sand fly saliva in human and experimental leishmaniasis: current insights. Scand J Immunol 2007; 66: 122-127.
6. Rohousová I, Volf P: Sand fly saliva: effects on host immune response and Leishmania transmission (review). Folia Parasitol (Praha) 2006; 53: 161-171.
7. Titus RG, Bishop JV, Meija JS: The immunomodulatory factors of arthropod saliva and the potential of these factors to serve as vaccine targets to prevent pathogen transmission. Parasite Immunol 2006; 28: 131-141.
8. Ghosh KN, Mukhopadhyay J: The effect of anti-sandfly saliva antibodies on Phlebotomus argentipes and Leishmania donovani . Int J Parasitol 1998; 28: 275-281.
9. Lima HC, Titus RG: Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infect Immun 1996; 64: 5442-5445.
10. Mbow ML, Bleyenberg JA, Hall LR, Titus RG: Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but upregulates a Th2, response in mice infected with Leishmania major . J Immunol 1998; 161: 5571-5577.
11. Norsworthy NB, Sun J, Elnaiem D, Lanzaro G, Soong L: Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect Immun 2004; 72: 1240-1247.
12. Titus R, Ribeiro J: Salivary gland lysates from the sand fly Lutzomyia longipalpis enhances Leishmania infectivity. Science 1988; 239: 1306-1308.
13. Lerner EA, Ribeiro JM, Nelson RJ, Lerner MR: Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. J Biol Chem 1991; 266: 11234-11236.
14. Lerner EA, Shoemaker CB: Maxadilan: cloning and functional expression of the gene encoding this potent vasodilator peptide. J Biol Chem 1992; 267: 1062-1066.
15. Moro O, Lerner EA: Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type 1 agonist. J Biol Chem 1997; 272: 966-970.
16. Lerner EA, Iuga AO, Reddy VB: Maxadilan, a PAC1 receptor agonist from sand flies. Peptides 2007; 28: 1651-1654.
17. Pereira P, Reddy VB, Kounga K, Bello Y, Lerner E: Maxadilan activates PAC1 receptors expressed in Xenopus laevis melanophores. Pigment Cell Res 2002; 15: 461-466.
18. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH: Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 64: 567-574.
19. Arimura A: Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul Pept 1992; 37: 287-303.
20. Arimura A, Shioda S: Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol 1995; 16: 53-88.
21. Reddy VB, Iuga AO, Kounga K, Lerner EA: Functional analysis of recombinant mutants of maxadilan with a PAC1 receptor-expressing melanophore cell line. J Biol Chem 2006; 24: 16197-16201.
22. Warren JB, Larkin SW, Coughlan M, Kajekar R, Williams TJ: Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo. Br J Pharmacol 1992; 106: 331-334.
23. Warren JB, Wilson AJ, Loi RK, Coughlan ML: Opposing roles of cyclic AMP in the vascular control of edema formation. FASEB J 1993; 7: 1394-1400.
24. Cardell LO, Stjärne P, Wagstaff SJ, Agusti C, Nadel JA: PACAP-induced plasma extravasation in rat skin. Reg Pept 1997; 71: 67-71.
25. Kinhult J, Adner M, Uddman R, Cardell LO: Pituitary adenylate cyclase-activating polypeptide, effects in the human nose. Clin Exp Allergy 2003; 33: 942-949.
26. Valenzuela JG, Garfield M, Rowton ED, Pham VM: Identification of the most abundant secreted proteins from the salivary glands of the sand fly Lutzomyia longipalpis , vector of Leishmania chagasi . J Exp Biol 2004; 207: 3717-3729.
27. Bozza M, Soares MB, Bozza PT, Satoskar AR, Diacovo TG, Brombacher T, Titus RG, Shoemaker CB, David JR: The PACAP-type 1 receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent on IL-10. Eur J Immunol 1998; 28: 3120-3127.
28. Soares MB, Titus RG, Shoemaker CB, David JR, Bozza M: The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-α and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor. J Immunol 1998; 160: 1811-1816.
29. Teixeira MJ, Teixeira CR, Andrade BB, Barral-Netto M, Aldina Barral A: Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol 2006; 22: 32-40.
30. Harfi I, D'Hondt S, Corazza F, Sariban E: Regulation of human polymorphonuclear leukocytes functions by the neuropeptide pituitary adenylate cyclase-activating polypeptide after activation of MAPKs. J Immunol 2004; 173: 4154-4163.
31. El Zein N, Badran BM, Sariban E: The neuropeptide pituitary adenylate cyclase-activating protein stimulates human monocytes by transactivation of the Trk/NGF pathway. Cell Signal 2007; 19: 152-162.
32. Svensjö E: Bradykinin and prostaglandin E1, E2 and F2-alpha-induced macromolecular leakage in the hamster cheek pouch. Prostaglandins Med 1978; 1: 397-410.
33. Svensjö E: The hamster cheek pouch as a model in microcirculation research. Eur Respir J Suppl 1990; 3: 595s-601s.
34. Svensjö E, Batista PR, Brodskyn CI, Silva R, Lima APC, Schmitz V, Saraiva EM, Pesquero JB, Mori MAS, Müller-Esterl W, Scharfstein J: Interplay between parasite cysteine proteases and the host kinin system modulates microvascular leakage and macrophage infection by promastigotes of the Leishmania donovani complex. Microbes Infect 2006; 8: 206-220.
35. Mayhan WG, Joyner WL: The effect of altering the external calcium concentration and a calcium channel blocker, verapamil, on microvascular leaky sites and dextran clearance in the hamster cheek pouch. Microvasc Res 1984; 28: 159-179.
36. Persson NH, Erlansson M, Svensjö E, Takolander R, Bergqvist D: The hamster cheek pouch - an experimental model to study postischemic macromolecular permeability. Int J Microcirc Clin Exp 1985; 4: 257-263.
37. Gawlowski DM, Duran WN: Dose-related effects of adenosine and bradykinin on microvascular permselectivity to macromolecules in the hamster cheek pouch. Circ Res 1986; 58: 348-355.
38. 4 -induced permeability increase in postcapillary venules and its inhibition by three different antiiflammatory drugs. Inflammation 1989; 13: 693-705.
39. Erlansson M, Bergqvist D, Persson NH, Svensjö E: Modification of postischemic increase of microvascular permeability in the hamster by iloprost. Prostaglandins 1991; 4: 157-168.
40. Armenante PM, Kim D, Duran WN: Experimental determination of linear correlation between in vivo TV intensity and vascular and tissue FITC-DX concentrations. Microvasc Res 1991; 42: 198-208.
41. Morris RV, Shoemaker CB, David JR, Lanzaro GC, Titus RG: Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection. J Immunol 2001; 167: 5226-5230.
42. Svensjö E: The hamster cheek pouch as a research model in inflammation; in Shepro D (ed): Microvascular Research - Biology and Pathology. Amsterdam, Elsevier, 2006, pp 195-207.
43. Brodie TM, Smith MC, Morris RV, Titus RG: Immunomodulatory effects of the Lutzomyia longipalpis salivary gland protein maxadilan on mouse macrophages. Infect Immun 2007; 75: 2359-2365.
44. Winzell MS, Ahrén B: Role of VIP and PACAP in islet function. Peptides 2007;28: 1805-1813.
45. Reglodi D, Borzsei R, Bagoly T, Boronkai A, Racz B, Tamas A, Kiss P, Horvath G, Brubel R, Nemeth J, Toth G, Helyes Z: Agonistic behavior of PACAP6-38 on sensory nerve terminals and cytotrophoblast cells. J Mol Neurosci 2008; 36: 270-278.
46. Grega GJ, Kline RI, Dobbins DE, Haddy FJ: Mechanisms of edema formation by histamine administered locally into canine forelimbs. Am J Physiol 1972; 223: 1165-1171.
47. Svensjö E, Arfors KE, Raymond RM, Grega GJ: Morphological and physiological correlation of bradykinin-induced macromolecular efflux. Am J Physiol 1979; 236:H600-H606.
48. Svensjö E, Andersson KE, Bouskela E, Cyrino FZ, Lindgren S: Effects of two vasodilatory phosphodiesterase inhibitors on bradykinin-induced permeability increase in the hamster cheek pouch. Agents Actions 1993; 39: 35-41.
49. Wheat WH, Pauken KE, Morris RV, Titus RG: Lutzomyia longipalpis salivary peptide maxadilan alters murine dendritic cell expression of CD80/86, CCR7, and cytokine secretion and reprograms dendritic cell-mediated cytokine release from cultures containing allogeneic T cells. J Immunol 2008; 180: 8286-8298.
50. Warburg A, Saraiva E, Lanzaro GC, Titus RG, Neva F: Saliva of Lutzomyia longipalpis sibling species differs in its composition and capacity to enhance leishmaniasis. Philos Trans R Soc Lond B Biol Sci 1994; 345: 223-230.
51. 2 receptors is required for induction of type-1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi . J Immunol 2006; 177: 6325-6335.
52. Scharfstein J, Schmitz V, Svensjö E, Granato A, Monteiro AC: Kininogens coordinate adaptive immunity through the proteolytic release of bradykinin, an endogenous danger signal driving dendritic cell maturation. Scand J Immunol 2007; 66: 128-136.